{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:41:48Z","timestamp":1790361708874,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,12]],"date-time":"2018-05-12T00:00:00Z","timestamp":1526083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s12149-018-1260-1","type":"journal-article","created":{"date-parts":[[2018,5,12]],"date-time":"2018-05-12T04:59:20Z","timestamp":1526101160000},"page":"410-416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["18F-FDG PET\/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin\u2019s lymphoma as predictors of treatment outcome and survival"],"prefix":"10.1007","volume":"32","author":[{"given":"Aatif","family":"Parvez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Tau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Hussey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Maganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ur","family":"Metser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,12]]},"reference":[{"key":"1260_CR1","doi-asserted-by":"publisher","first-page":"30483058","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, M\u00fceller SP, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 2014;32:3048\u20133058.","journal-title":"J Clin Oncol"},{"key":"1260_CR2","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","volume":"116","author":"B Coiffier","year":"2010","unstructured":"Coiffier B, Thieblemont C, Van Den Neste E, Lepeu G, Plantier I, Castaigne S, et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte. Blood. 2010;116:2040\u20135.","journal-title":"Blood"},{"key":"1260_CR3","doi-asserted-by":"publisher","first-page":"e326","DOI":"10.1038\/bcj.2015.51","volume":"5","author":"E Malek","year":"2015","unstructured":"Malek E, Sendilnathan A, Yellu M, Petersen A, Fernandez-Ulloa M, Driscoll JJ. Metabolic tumor volume on interim PET is a better predictor of outcome in diffuse large B-cell lymphoma than semiquantitative methods. Blood Cancer J. 2015;5:e326.","journal-title":"Blood Cancer J"},{"issue":"2","key":"1260_CR4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1179\/1607845415Y.0000000033","volume":"21","author":"M Xie","year":"2016","unstructured":"Xie M, Zhai W, Cheng S, Zhang H, Xie Y, He W. Predictive value of F-18 FDG PET\/CT quantization parameters for progression-free survival in patients with diffuse large B-cell lymphoma. Hematology. 2016;21(2):99\u2013105.","journal-title":"Hematology"},{"key":"1260_CR5","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00259-016-3315-7","volume":"43","author":"NG Mikhaeel","year":"2016","unstructured":"Mikhaeel NG, Smith D, Dunn JT, Phillips M, M\u00f8ller H, Fields PA, et al. Combination of baseline metabolic tumour volume and early response on PET\/CT improves progression-free survival prediction in DLBCL. Eur J Nucl Med Mol Imaging. 2016;43:1209\u201319.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1260_CR6","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1158\/1078-0432.CCR-15-2825","volume":"22","author":"AS Cottereau","year":"2016","unstructured":"Cottereau AS, Lanic H, Mareschal S, Meignan M, Vera P, Tilly H, et al. Molecular profile and FDG-PET\/CT total metabolic tumor volume improve risk classification at diagnosis for patients with diffuse large B-cell lymphoma. Clin Cancer Res. 2016;22:3801\u20139.","journal-title":"Clin Cancer Res"},{"key":"1260_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1148\/radiol.12111607","volume":"264","author":"O Gevaert","year":"2012","unstructured":"Gevaert O, Xu J, Hoang CD, Leung AN, Xu Y, Quon A, et al. Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data\u2014methods and preliminary results. Radiology. 2012;264:387\u201396.","journal-title":"Radiology"},{"key":"1260_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1148\/radiol.13130663","volume":"270","author":"CA Karlo","year":"2014","unstructured":"Karlo CA, Di Paolo PL, Chaim J, Hakimi AA, Ostrovnaya I, Russo P, et al. Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. Radiology. 2014;270:464\u201371.","journal-title":"Radiology"},{"key":"1260_CR9","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.3390\/ijms13021951","volume":"13","author":"SJ Diaz-Cano","year":"2012","unstructured":"Diaz-Cano SJ. Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design. Int J Mol Sci. 2012;13:1951\u20132011.","journal-title":"Int J Mol Sci"},{"key":"1260_CR10","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.mri.2012.06.010","volume":"30","author":"V Kumar","year":"2012","unstructured":"Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, et al. Radiomics: the process and the challenges. Magn Reson Imaging. 2012;30:1234\u201348.","journal-title":"Magn Reson Imaging"},{"key":"1260_CR11","first-page":"S156-S157","volume":"43","author":"C Nioche","year":"2016","unstructured":"Nioche C, Orlhac F, Soussan M, Boughdad S, Alberini J, Buvat I. A software for characterizing intra-tumor heterogeneity in multimodality imaging and establishing reference charts. Eur J Nucl Med Mol Imaging. 2016;43:S156-S157.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1260_CR12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s12185-011-0822-y","volume":"93","author":"D Chihara","year":"2011","unstructured":"Chihara D, Oki Y, Onoda H, Taji H, Yamamoto K, Tamaki T, et al. High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma. Int J Hematol. 2011;93:502\u20138.","journal-title":"Int J Hematol"},{"key":"1260_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s13139-009-0009-0","volume":"44","author":"XC Nguygen","year":"2010","unstructured":"Nguygen XC, Lee WW, Amin AM, Eo JS, Bang SM, Lee JS, et al. Tumor burden assessed by the maximum standardized uptake value and greatest diameter on FDG-PET predicts prognosis in untreated diffuse large B-cell lymphoma. Nucl Med Mol Imaging. 2010;44:39\u201344.","journal-title":"Nucl Med Mol Imaging"},{"key":"1260_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00277-012-1602-3","volume":"92","author":"Y Miyazaki","year":"2013","unstructured":"Miyazaki Y, Nawa Y, Miyagawa M, Kohashi S, Nakase K, Yasukawa M, et al. Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma. Ann Hematol. 2013;92:239\u201344.","journal-title":"Ann Hematol"},{"key":"1260_CR15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1179\/1607845415Y.0000000033","volume":"21","author":"M Xie","year":"2016","unstructured":"Xie M, Zhai W, Cheng S, Zhang H, Xie Y, He W. Predictive value of F-18 FDG PET\/CT quantization parameters for progression-free survival in patients with diffuse large B-cell lymphoma. Hematology. 2016;21:99\u2013105.","journal-title":"Hematology"},{"key":"1260_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","volume":"37","author":"R Boellaard","year":"2010","unstructured":"Boellaard R, O\u2019Doherty MJ, Weber WA, Giammarile F, Tatsch K, Eschner W, et al. FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37:181\u2013200.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1260_CR17","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.3109\/10428194.2013.784967","volume":"54","author":"BS Dabaja","year":"2013","unstructured":"Dabaja BS, Phan J, Mawlawi O, Medeiros LJ, Etzel C, Liang FW, et al. Clinical implications of PET-negative residual CT masses after chemotherapy for diffuse large B-cell lymphoma. Leuk Lymphoma. 2013;54:2631\u20138.","journal-title":"Leuk Lymphoma"}],"updated-by":[{"DOI":"10.1007\/s12149-018-1271-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T00:00:00Z","timestamp":1529452800000}}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-018-1260-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-018-1260-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-018-1260-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T23:31:22Z","timestamp":1557617482000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-018-1260-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,12]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["1260"],"URL":"https:\/\/doi.org\/10.1007\/s12149-018-1260-1","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12149-018-1271-y","asserted-by":"object"}]},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,12]]},"assertion":[{"value":"9 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication of the article, the title was incorrectly.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}